Synchronous mucinous tumors of the appendix and the ovary associated with pseudomyxoma peritonei: A clinicopathologic study of six cases with comparative analysis of c-Ki-ras mutations

American Journal of Surgical Pathology

Volumn 20, Issue 6, 1996, Pages 739-746

  Cuatrecasas, Miriam ^a   Matias Guiu, Xavier ^a   Prat, Jaime ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Appendix; c Ki ras; Clonality; Mucinous tumors; Oncogenes; Ovary; Peritoneum; Pseudomyxoma peritonei; Synchronous neoplasms

Indexed keywords

APPENDIX TUMOR; ARTICLE; CARCINOGENESIS; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; OVARY TUMOR; PERITONEUM PSEUDOMYXOMA; TUMOR CLASSIFICATION; TUMOR LOCALIZATION;

ADENOCARCINOMA, MUCINOUS; AGED; APPENDICEAL NEOPLASMS; BASE SEQUENCE; DNA, NEOPLASM; FEMALE; GENES, RAS; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PSEUDOMYXOMA PERITONEI;

EID: 0029968242     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199606000-00012     Document Type: Article

References (27)

1. Bos JL. ras Oncogenes in human cancer: a review. Cancer Res 1989;49:4682-9.
2. Capella G, Cronauer-Mitra S, Peinado MG, Perucho M. Frequency and spectrum of mutations al codons 12 and 13 of the c-K-ras gene in human tumors. Environ Health Perspect 1991;93:125-31.
3. Enomoto T, Weghorsst C, Inoue M, Tanizawa O, Rice J. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary. Am J Pathol 1991;139:777-85.
4. Ichikawa Y, Nishida M, Suzuki H, et al. Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors. Cancer Res 1994;54:33-5.
5. Jiang W, Kahn SM, Guillem JG, Lu SH, Weinstein IB. Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal and gastric cancer. Oncogene 1989;4:923-8.
6. Kaern J, Trope CG, Abeler VM. A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982: a review of clinicopathologic features and treatment modalities. Cancer 1993; 71:1810-20.
7. Kahn MA, Demopoulos RI. Mucinous ovarian tumors with pseudomyxoma peritonei: a clinicopatholoeical study. Int J Gynecol Pathol 1992;11:15-23.
8. Kobayashi T, Tsuda H, Noguchi M, et al. Association of point mutation in c-Ki-ras oncogene in lung adenocarcinoma with particular reference to cytologie subtypes. Cancer 1990;66:289-94.
9. Kumar R, Barbacid M. Oncogene detection at the single cell level. Onconene 1988;3:647-51.
10. Lash R, Hart W. Intestinal adenocarcinomas metastatic to the ovaries. A clinicopathologic evaluation of 22 cases. Am J Surg Pathol 1987;11:114-21.
11. Losi L, Benhattar J, Costa J. Stability of K-ras mutations throughout the natural history of human colorectal cancer. Eur J Cancer 1992;28A:11150-20.
12. Mies C, Houldsworth J, Chaganti RSK. Extraction of DNA from paraffin blocks for Southern Blot analysis. Am J Surg Pathol 1991;15:169-74.
13. Mok S, Bell D, Knapp R, et al. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res 1993;53:1489-92.
14. Noumoff J, LiVolsi V, Mikuta J, Faruqi S. An insight into the etiology of pseudomyxoma peritonei by chromosomal and immunohistochemical analysis [Abstract]. Gynecol Oncol 1993;49:136.
15. Pilotti S, Manenti G, De Georgio L, Rilke F, Chiarle R, Pierotti MA. Identification of the same HRAS1 mutation in a primary minimally invasive follicular carcinoma of the thyroid gland and its bone metastasis developed 15 years later. Diagn Mol Pathol 1995;4:73-4.
16. Praison R, Hart W, Petras R. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Am J Surg Pathol 1994;18:591-603.
17. Ronnett BM, Kurman RJ, Zahn CM, et al. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol 1995;26:509-24.
18. Seidman JD, Elsayed AM, Sobin LH, Tavassoli FA. Association of mucinous tumors of the ovary and appendix: a clinicopathologic study of 25 cases. Am J Surg Pathol 1993; 17:22-34.
19. Smith J, Kemeny N, Caldwell C, Banner P, Sigurdson E, Huvos A. Pseudomyxoma Peritonei of appendiceal origin. The Memorial Sloan-Kettering Cancer Center experience. Cancer 1992;70:396-401.
20. Sugio K, Inoue T, Inoue K, et al. Different site mutation of the K-ras gene in a patient with metachronous double lung cancers. Amicancer Res (Greece) 1993;13:2469-71.
21. Sumithran E, Susil BJ. Concomitant mucinous tumors of appendix and ovary: result of a neoplastic field change? Cancer 1992;70:2980-3.
22. Teneriello M, Ebina M, Linnoila R, et al. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res 1993;53:3103-8.
23. Terunuma H, Hayakashi T, Tsuneyoshi T, Fujita M, Kino I, Baba S. Mutational heterogeneity among individual tumors in a case of multiple primary malignancy of the colon. Jpn J Clin Oncol 1993;23:350-5.
24. Volgestein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32.
25. Yanagisawa A, Ohtake K, Ohashi K, et al. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 1993; 53:953-6.
26. Young RH, Gilks CB, Scully RE. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritoneii: a clinicopathological analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol 1991;15:415-29.
27. Young R, Hart W. Metastases from carcinomas of the pancreas simulating primary mucinous tumors of the ovary. A report of seven cases. Am J Surg Pathol 1989;13:748-56.